SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-053502
Filing Date
2023-05-01
Accepted
2023-05-01 07:30:32
Documents
13
Period of Report
2023-05-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2314004d1_8k.htm   iXBRL 8-K 32308
2 EXHIBIT 10.1 tm2314004d1_ex10-1.htm EX-10.1 69362
  Complete submission text file 0001104659-23-053502.txt   296240

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cgtx-20230501.xsd EX-101.SCH 3024
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cgtx-20230501_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cgtx-20230501_pre.xml EX-101.PRE 22589
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2314004d1_8k_htm.xml XML 3613
Mailing Address 2500 WESTCHESTER AVE PURCHASE NY 10577
Business Address 2403 SIDNEY STREET SUITE 261 PITTSBURGH PA 15203 412-481-2210
COGNITION THERAPEUTICS INC (Filer) CIK: 0001455365 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40886 | Film No.: 23870015
SIC: 2836 Biological Products, (No Diagnostic Substances)